{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-07-11T09:11:09.429167+00:00","company":{"ticker":"TAOX","cik":1571934,"company_name":"TAO Synergies Inc."},"pagination":{"limit":100,"returned":21,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{"contract_counterparty":[{"display_name":"Cannasoul Analytics Ltd.","detail":"equity_purchase","count":2,"first_seen":"2023-11-06T23:59:59+00:00","last_seen":"2023-11-06T23:59:59+00:00","evidence_fact_ids":[98563,98564]},{"display_name":"Cannasoul Analytics Ltd., the founders of Cannasoul and certain investors in Cannasoul","detail":"equity_purchase","count":1,"first_seen":"2023-11-06T23:59:59+00:00","last_seen":"2023-11-06T23:59:59+00:00","evidence_fact_ids":[98565]}]},"facts":[{"fact_type":"equity_issuance","fact_key":"9180650295cbd18a1d36051b107fc90268660ed3","cik":1571934,"ticker":"TAOX","company_name":"TAO Synergies Inc.","filed_at":"2025-10-14T23:59:59+00:00","payload":{"action":"private_placement","consideration_text":"aggregate gross proceeds...expected to be $11.0 million","effective_date":"2025-10-13","item_codes_triggered":["3.02"],"purchaser":"certain accredited investors","security_type":"warrant","shares_text":"warrants to purchase up to an aggregate of 1,375,000 shares of Common Stock"},"claim":"TAO Synergies Inc. issued warrants to purchase up to an aggregate of 1,375,000 shares of Common Stock of warrant to certain accredited investors for aggregate gross proceeds...expected to be $11.0 million.","evidence_excerpt":"is expected to occur on October 15, 2025, subject to the satisfaction of customary closing conditions.\nThe aggregate gross proceeds from the Private Placement are expected to be $11.0 million. The Company expects to use the net proceeds\nfrom the Private Placement for general corporate purposes and working capital. The\nPurchase Agreement contains certain","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-25-098909","anchor_url":"https://secwatch.observer/filing/0001104659-25-098909#claim-9180650295cbd18a1d36051b107fc90268660ed3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465925098909/0001104659-25-098909-index.htm"},{"fact_type":"equity_issuance","fact_key":"3381290b88f3f7fa4139eba6d39fec8efa101600","cik":1571934,"ticker":"TAOX","company_name":"TAO Synergies Inc.","filed_at":"2025-10-14T23:59:59+00:00","payload":{"action":"private_placement","consideration_text":"aggregate gross proceeds...expected to be $11.0 million","effective_date":"2025-10-13","item_codes_triggered":["3.02"],"purchaser":"certain accredited investors","security_type":"preferred_stock","shares_text":"11,000 shares of the Company's newly designated Series E convertible preferred stock"},"claim":"TAO Synergies Inc. issued 11,000 shares of the Company's newly designated Series E convertible preferred stock of preferred stock to certain accredited investors for aggregate gross proceeds...expected to be $11.0 million.","evidence_excerpt":"is expected to occur on October 15, 2025, subject to the satisfaction of customary closing conditions.\nThe aggregate gross proceeds from the Private Placement are expected to be $11.0 million. The Company expects to use the net proceeds\nfrom the Private Placement for general corporate purposes and working capital. The\nPurchase Agreement contains certain","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-25-098909","anchor_url":"https://secwatch.observer/filing/0001104659-25-098909#claim-3381290b88f3f7fa4139eba6d39fec8efa101600","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465925098909/0001104659-25-098909-index.htm"},{"fact_type":"governance_change","fact_key":"ab3f5bce7ba650eec3138f916da49e481608d229","cik":1571934,"ticker":"TAOX","company_name":"TAO Synergies Inc.","filed_at":"2025-06-27T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2025-06-26","item_codes_triggered":["5.03"],"summary_text":"Company amended its Amended and Restated Certificate of Incorporation to change its corporate name to TAO Synergies Inc."},"claim":"TAO Synergies Inc.: Company amended its Amended and Restated Certificate of Incorporation to change its corporate name to TAO Synergies Inc (effective 2025-06-26).","evidence_excerpt":"On June 25, 2025, the Company filed a certificate of amendment to its Amended and Restated Certificate of Incorporation (“Amendment”) with the Secretary of State for the State of Delaware to change its name to TAO Synergies Inc. (the “Name Change”). The Name Change and Amendment became effective at 8:00 a.m. Eastern Time on June 26, 2025.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-25-063601","anchor_url":"https://secwatch.observer/filing/0001104659-25-063601#claim-ab3f5bce7ba650eec3138f916da49e481608d229","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465925063601/0001104659-25-063601-index.htm"},{"fact_type":"executive_change","fact_key":"873fca514e","cik":1571934,"ticker":"TAOX","company_name":"TAO Synergies Inc.","filed_at":"2025-06-09T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-06-06","interim":false,"role":"Executive Chairman","role_category":"chair","successor_name":null,"successor_named":false},"claim":"Joshua Silverman was appointed as Executive Chairman at TAO Synergies Inc..","evidence_excerpt":"On June 6, 2025, Mr. Joshua Silverman was appointed as Executive Chairman of the Company’s board of directors and in consideration of his new role, Mr. Silverman will be paid a monthly salary of $30,000 per month.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-25-057640","anchor_url":"https://secwatch.observer/filing/0001104659-25-057640#claim-873fca514e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465925057640/0001104659-25-057640-index.htm"},{"fact_type":"executive_change","fact_key":"1eb878440a","cik":1571934,"ticker":"TAOX","company_name":"TAO Synergies Inc.","filed_at":"2025-06-09T23:59:59+00:00","payload":{"action":"resigned","action_category":"role_change","departure_tone":"routine","effective_date":"2025-06-08","interim":false,"role":"Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Alan J. Tuchman resigned as Chief Executive Officer at TAO Synergies Inc..","evidence_excerpt":"On June 8, 2025, Dr. Alan J. Tuchman resigned as Chief Executive Officer and director of the Company, effective June 8, 2025. Dr. Tuchman will serve as Chief Medical Officer of the Company.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-25-057640","anchor_url":"https://secwatch.observer/filing/0001104659-25-057640#claim-1eb878440a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465925057640/0001104659-25-057640-index.htm"},{"fact_type":"executive_change","fact_key":"4842210ab1","cik":1571934,"ticker":"TAOX","company_name":"TAO Synergies Inc.","filed_at":"2025-06-09T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2025-06-04","interim":false,"role":"Chief Science Officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Daniel L. Alkon resigned as Chief Science Officer at TAO Synergies Inc..","evidence_excerpt":"On June 4, 2025, Dr. Daniel L. Alkon resigned as an officer, director and Chief Science Officer of the Company to become a consultant working with the Company’s newly established Bryostatin Development Committee","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-25-057640","anchor_url":"https://secwatch.observer/filing/0001104659-25-057640#claim-4842210ab1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465925057640/0001104659-25-057640-index.htm"},{"fact_type":"governance_change","fact_key":"3e266e7d3bfd56a69307bbacf3c90a10f9683998","cik":1571934,"ticker":"TAOX","company_name":"TAO Synergies Inc.","filed_at":"2024-04-04T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2024-04-04","item_codes_triggered":["5.03"],"summary_text":"Filed Certificate of Amendment to effect a 1-for-25 reverse stock split of common stock, effective 5:00 p.m. Eastern Time on April 4, 2024."},"claim":"TAO Synergies Inc.: Filed Certificate of Amendment to effect a 1-for-25 reverse stock split of common stock, effective 5:00 p.m. Eastern Time on April 4, 2024 (effective 2024-04-04).","evidence_excerpt":"On April 4, 2024, the Company filed with the Secretary of State of the State of Delaware the Certificate of Amendment to effect a one-time reverse stock split of the Company’s common stock, at a ratio of 1-for-25 (the “Reverse Stock Split”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-24-043683","anchor_url":"https://secwatch.observer/filing/0001104659-24-043683#claim-3e266e7d3bfd56a69307bbacf3c90a10f9683998","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465924043683/0001104659-24-043683-index.htm"},{"fact_type":"shareholder_vote","fact_key":"1a6ba47afc023f75805b851c4bc02786095fcdb6","cik":1571934,"ticker":"TAOX","company_name":"TAO Synergies Inc.","filed_at":"2023-12-21T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-12-31","outcome":"passed","proposal_text":"Ratification of Selection of Independent Registered Public Accounting Firm - Marcum LLP","proposal_type":"auditor_ratification","results":[{"broker_non_votes":null,"subject":null,"votes_abstain":"287,495","votes_against":"994,599","votes_for":"10,660,952","votes_withheld":null}]},"claim":"TAO Synergies Inc. shareholders approved Ratification of Selection of Independent Registered Public Accounting Firm - Marcum LLP at the 2023-12-31 meeting.","evidence_excerpt":"Proposal 4 - Ratification of Selection of Independent Registered Public Accounting Firm. The ratification of appointment of Marcum LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. Shares Voted For Shares Voted Against Abstentions 10,660,952 994,599 287,495","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-23-128289","anchor_url":"https://secwatch.observer/filing/0001104659-23-128289#claim-1a6ba47afc023f75805b851c4bc02786095fcdb6","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465923128289/0001104659-23-128289-index.htm"},{"fact_type":"shareholder_vote","fact_key":"db9f1ace05b4ef1d85bfc1ea63728081e8ff8b87","cik":1571934,"ticker":"TAOX","company_name":"TAO Synergies Inc.","filed_at":"2023-12-21T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":null,"outcome":"passed","proposal_text":"Approval of Amendment to the Synaptogenix, Inc. 2020 Equity Incentive Plan","proposal_type":"equity_plan","results":[{"broker_non_votes":"5,986,368","subject":null,"votes_abstain":"276,226","votes_against":"2,324,244","votes_for":"3,356,208","votes_withheld":null}]},"claim":"TAO Synergies Inc. shareholders approved Approval of Amendment to the Synaptogenix, Inc. 2020 Equity Incentive Plan.","evidence_excerpt":"Proposal 3 - Approval of Amendment to the Synaptogenix, Inc. 2020 Equity Incentive Plan Our stockholders voted to approve an amendment to our Plan to increase the total number of shares of Common Stock authorized for issuance thereunder from 1,375,000 shares of Common Stock to an aggregate of 4,375,000 shares of Common Stock by the following votes: Shares Voted For Shares Voted Against Abstentions Broker Non-Votes 3,356,208 2,324,244 276,226 5,986,368","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-23-128289","anchor_url":"https://secwatch.observer/filing/0001104659-23-128289#claim-db9f1ace05b4ef1d85bfc1ea63728081e8ff8b87","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465923128289/0001104659-23-128289-index.htm"},{"fact_type":"shareholder_vote","fact_key":"162f8a5c92e9940ccf58f88f18ae41ab64721683","cik":1571934,"ticker":"TAOX","company_name":"TAO Synergies Inc.","filed_at":"2023-12-21T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":null,"outcome":"passed","proposal_text":"Board Authorization to Effect a Reverse Stock Split","proposal_type":"reverse_split","results":[{"broker_non_votes":null,"subject":null,"votes_abstain":"188,441","votes_against":"3,093,253","votes_for":"8,661,349","votes_withheld":null}]},"claim":"TAO Synergies Inc. shareholders approved Board Authorization to Effect a Reverse Stock Split.","evidence_excerpt":"Proposal 2 – Board Authorization to Effect a Reverse Stock Split Our stockholders voted to authorize our board of directors (the “Board”) to effect one reverse stock split of our outstanding shares of Common Stock, at a ratio between 1-for-8 and 1-for-25 (or any number in between), at such time, if any, as our Board shall determine, in its sole discretion. Shares Voted For Shares Voted Against Abstentions 8,661,349 3,093,253 188,441","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-23-128289","anchor_url":"https://secwatch.observer/filing/0001104659-23-128289#claim-162f8a5c92e9940ccf58f88f18ae41ab64721683","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465923128289/0001104659-23-128289-index.htm"},{"fact_type":"shareholder_vote","fact_key":"166a63bee5d41f19196f78e76cf2287f266bbdd6","cik":1571934,"ticker":"TAOX","company_name":"TAO Synergies Inc.","filed_at":"2023-12-21T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":null,"outcome":"passed","proposal_text":"Election of two directors to serve until the 2026 annual meeting","proposal_type":"director_election","results":[{"broker_non_votes":"5,986,368","subject":"Alan Tuchman","votes_abstain":null,"votes_against":null,"votes_for":"4,505,521","votes_withheld":"1,451,157"},{"broker_non_votes":"5,986,368","subject":"Daniel L. Alkon","votes_abstain":null,"votes_against":null,"votes_for":"4,728,376","votes_withheld":"1,228,302"}]},"claim":"TAO Synergies Inc. shareholders approved Election of two directors to serve until the 2026 annual meeting.","evidence_excerpt":"Proposal 1 - Election of Directors Our stockholders voted to elect two directors to hold office until the 2026 annual meeting of stockholders, and until their respective successors are elected and qualified, by the following votes: Nominee For Withheld Broker Non-Votes Alan Tuchman 4,505,521 1,451,157 5,986,368 Daniel L. Alkon 4,728,376 1,228,302 5,986,368","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-23-128289","anchor_url":"https://secwatch.observer/filing/0001104659-23-128289#claim-166a63bee5d41f19196f78e76cf2287f266bbdd6","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465923128289/0001104659-23-128289-index.htm"},{"fact_type":"material_agreement","fact_key":"d996f1c230ad05088bdf31e07214f82163bb2b89","cik":1571934,"ticker":"TAOX","company_name":"TAO Synergies Inc.","filed_at":"2023-11-06T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Investor Rights Agreement","agreement_type":"equity_purchase","counterparty":"Cannasoul Analytics Ltd., the founders of Cannasoul and certain investors in Cannasoul","effective_date":"2023-10-31","item_codes_triggered":["1.01"],"value_text":null},"claim":"TAO Synergies Inc. entered into Investor Rights Agreement with Cannasoul Analytics Ltd., the founders of Cannasoul and certain investors in Cannasoul (effective 2023-10-31).","evidence_excerpt":"Also on October 31, 2023, the Company entered into an investor rights agreement (the “Investor Rights Agreement”) with Cannasoul, the founders of Cannasoul and certain investors in Cannasoul (the Company and the other investors collectively, the “Investors”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-23-114810","anchor_url":"https://secwatch.observer/filing/0001104659-23-114810#claim-d996f1c230ad05088bdf31e07214f82163bb2b89","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465923114810/0001104659-23-114810-index.htm"},{"fact_type":"material_agreement","fact_key":"1d95cd064b977ffcdcd800cf7a10f1ef0360ef16","cik":1571934,"ticker":"TAOX","company_name":"TAO Synergies Inc.","filed_at":"2023-11-06T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Collaboration Agreement","agreement_type":"collaboration","counterparty":"Cannasoul Analytics Ltd.","effective_date":"2023-10-31","item_codes_triggered":["1.01"],"value_text":null},"claim":"TAO Synergies Inc. entered into Collaboration Agreement with Cannasoul Analytics Ltd. (effective 2023-10-31).","evidence_excerpt":"Pursuant to a collaboration agreement entered into by the Company and Cannasoul on October 31, 2023 (the “Collaboration Agreement”), the parties agreed to form a joint research committee with equal representation from the Company and Cannasoul (the “JRC”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-23-114810","anchor_url":"https://secwatch.observer/filing/0001104659-23-114810#claim-1d95cd064b977ffcdcd800cf7a10f1ef0360ef16","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465923114810/0001104659-23-114810-index.htm"},{"fact_type":"material_agreement","fact_key":"9f4ea8b85b304709077c5a16043c44c2d88f84e1","cik":1571934,"ticker":"TAOX","company_name":"TAO Synergies Inc.","filed_at":"2023-11-06T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Purchase Agreement","agreement_type":"equity_purchase","counterparty":"Cannasoul Analytics Ltd.","effective_date":"2023-10-31","item_codes_triggered":["1.01"],"value_text":null},"claim":"TAO Synergies Inc. entered into Purchase Agreement with Cannasoul Analytics Ltd. (effective 2023-10-31).","evidence_excerpt":"On October 31, 2023, Synaptogenix, Inc. (the “Company”) entered into a share purchase agreement (the “Purchase Agreement”) with Cannasoul Analytics Ltd. (“Cannasoul”), pursuant to which the Company agreed to purchase from Cannasoul (i) 12,737 shares of Cannasoul’s Series A preferred shares, no par value per share (the “Preferred Shares”), at a price of $44.1550 per Preferred Share and (ii) a convertible preferred note in an aggregate amount of up to $1,437,598.49 (the “Initial Convertible Note”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-23-114810","anchor_url":"https://secwatch.observer/filing/0001104659-23-114810#claim-9f4ea8b85b304709077c5a16043c44c2d88f84e1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465923114810/0001104659-23-114810-index.htm"},{"fact_type":"governance_change","fact_key":"47395f3f4ae4d8dd83ffea65884bd918f6f7ff19","cik":1571934,"ticker":"TAOX","company_name":"TAO Synergies Inc.","filed_at":"2023-09-22T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2023-09-22","item_codes_triggered":["5.03"],"summary_text":"Amended terms of Series B Convertible Preferred Stock to allow mutual agreement on payment method and calculation adjustments during Equity Conditions Failure"},"claim":"TAO Synergies Inc.: Amended terms of Series B Convertible Preferred Stock to allow mutual agreement on payment method and calculation adjustments during Equity Conditions Failure (effective 2023-09-22).","evidence_excerpt":"On September 22, 2023, the Company filed a Certificate of Amendment to the Certificate of Designations (the “Amendment”) with the Delaware Secretary of State. The Amendment amended the terms of the Preferred Shares by providing that the Company and the holders of the Preferred Shares (the “Investors”) shall be permitted to mutually agree, in connection with any waiver of an Equity Conditions Failure (as defined in the Certificate of Designations), as to (i) whether the monthly amortization payments made to the Investors will be made in cash or shares of common stock, (ii) the methodology for calculating any applicable true-up shares required to be paid in connection with an amortization payment (including whether such true-up shares will be paid in cash or shares of common stock) and for calculating the conversion price in connection with any accelerated conversions, and (iii) whether any premium will apply in connection with any payment of true-up shares in cash instead of shares of c","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-23-103184","anchor_url":"https://secwatch.observer/filing/0001104659-23-103184#claim-47395f3f4ae4d8dd83ffea65884bd918f6f7ff19","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465923103184/0001104659-23-103184-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"742d644eda4a305b6f7240d7ffd7dbc511848473","cik":1571934,"ticker":"TAOX","company_name":"TAO Synergies Inc.","filed_at":"2023-04-28T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":"2023-10-23","deficiency_type":"minimum_bid_price","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":"Minimum closing bid price of $1.00 per share","notice_date":"2023-04-24","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5550(a)(2)","5810(c)(3)(A)"],"rules_cited_in_text":true},"claim":"TAO Synergies Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).","evidence_excerpt":"April 24, 2023, Synaptogenix,\nInc. (the “Company”) received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”)\nnotifying the Company that for the preceding 30 consecutive business days, the Company’s common stock did not maintain a minimum\nclosing bid price of $1.00 per share as required by Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”).\nThe notice has no immediate effect on the listing or trading of the Company’s common stock, and the common stock will continue to\ntrade on The Nasdaq Capital Market under the symbol “SNPX”","confidence":0.99,"filing_url":"https://secwatch.observer/filing/0001104659-23-053140","anchor_url":"https://secwatch.observer/filing/0001104659-23-053140#claim-742d644eda4a305b6f7240d7ffd7dbc511848473","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465923053140/0001104659-23-053140-index.htm"},{"fact_type":"shareholder_vote","fact_key":"3791bbf572554c2742dc91cdafad7baa8a7ada76","cik":1571934,"ticker":"TAOX","company_name":"TAO Synergies Inc.","filed_at":"2023-04-14T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-04-14","outcome":"passed","proposal_text":"Authorization of Issuance of Common Stock under Nasdaq Listing Rule 5635(d)","proposal_type":"other","results":[{"broker_non_votes":null,"subject":null,"votes_abstain":"55,679","votes_against":"791,292","votes_for":"2,077,004","votes_withheld":null}]},"claim":"TAO Synergies Inc. shareholders approved Authorization of Issuance of Common Stock under Nasdaq Listing Rule 5635(d) at the 2023-04-14 meeting.","evidence_excerpt":"Proposal – Authorization of Issuance of Common Stock The Company’s stockholders voted to authorize, for purposes of complying with Nasdaq Listing Rule 5635(d), of the issuance of shares of Common Stock underlying shares of convertible preferred stock and warrants issued by the Company pursuant to the terms of that certain Securities Purchase Agreement, dated November 17, 2022, by and among the Company and the investors named therein, in an amount equal to or in excess of 20% of Common Stock outstanding before the issuance of such convertible preferred stock and warrants (including the amortization payments made to the holders of convertible preferred stock in the form of issuance of common stock and upon the operation of  anti-dilution provisions contained in such convertible preferred stock and warrants), by the following votes: Shares Voted For Shares Voted Against Abstentions 2,077,004 791,292 55,679","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-23-045665","anchor_url":"https://secwatch.observer/filing/0001104659-23-045665#claim-3791bbf572554c2742dc91cdafad7baa8a7ada76","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465923045665/0001104659-23-045665-index.htm"},{"fact_type":"governance_change","fact_key":"9486442c44165df2e2169d64bb2060ce18f2e1da","cik":1571934,"ticker":"TAOX","company_name":"TAO Synergies Inc.","filed_at":"2022-12-28T23:59:59+00:00","payload":{"change_type":"bylaw_amendment","effective_date":"2022-12-27","item_codes_triggered":["5.03"],"summary_text":"修改章程以降低股东大会的法定人数要求，从多数改为至少三分之一"},"claim":"TAO Synergies Inc.: 修改章程以降低股东大会的法定人数要求，从多数改为至少三分之一 (effective 2022-12-27).","evidence_excerpt":"On December 27, 2022, the Board of Directors of Synaptogenix, Inc. (the “Company”) approved an amendment (the “Amendment”) to the bylaws of the Company (the “Bylaws”). The Amendment, which became effective immediately, amends and restates Article 1, Section 4 of the Bylaws to modify the quorum requirement for meetings of the stockholders of the Company to provide that the presence, in person or by proxy, of holders of at least one-third of the issued and outstanding shares of stock of the Company entitled to vote at such meeting will constitute a quorum at all meetings of the stockholders.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-22-130531","anchor_url":"https://secwatch.observer/filing/0001104659-22-130531#claim-9486442c44165df2e2169d64bb2060ce18f2e1da","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465922130531/0001104659-22-130531-index.htm"},{"fact_type":"governance_change","fact_key":"61d9fa15f4ba27eca514851c55211a267544330a","cik":1571934,"ticker":"TAOX","company_name":"TAO Synergies Inc.","filed_at":"2022-11-22T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2022-11-21","item_codes_triggered":["5.03"],"summary_text":"Created Series B Convertible Preferred Stock via Certificate of Designations"},"claim":"TAO Synergies Inc.: Created Series B Convertible Preferred Stock via Certificate of Designations (effective 2022-11-21).","evidence_excerpt":"On November 21, 2022, Synaptogenix, Inc. (the “Company”) filed a Certificate of Designations of Series B Convertible Preferred Stock of Synaptogenix, Inc. with the Secretary of State of the State of Delaware (the “Certificate of Designations”), thereby creating a new series of preferred stock of the Company designated as “Series B Convertible Preferred Stock” (the “Preferred Shares”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-22-121017","anchor_url":"https://secwatch.observer/filing/0001104659-22-121017#claim-61d9fa15f4ba27eca514851c55211a267544330a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465922121017/0001104659-22-121017-index.htm"},{"fact_type":"material_agreement","fact_key":"c9b8730a9d72f9bd9aaef9d21a16b4a1f0ac1924","cik":1571934,"ticker":"TAOX","company_name":"TAO Synergies Inc.","filed_at":"2022-11-18T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreement","agreement_type":"equity_purchase","counterparty":"certain accredited investors","effective_date":"2022-11-17","item_codes_triggered":["1.01"],"value_text":"$15 million"},"claim":"TAO Synergies Inc. entered into Securities Purchase Agreement with certain accredited investors valued at $15 million (effective 2022-11-17).","evidence_excerpt":"On November 17, 2022, Synaptogenix, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which it agreed to sell to the Investors (i) an aggregate of 15,000 shares of the Company’s newly-designated Series B convertible preferred stock with a stated value of $1,000 per share, initially convertible into up to 1,935,485 shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) at a conversion price of $7.75 per share (the “Preferred Shares”), and (ii) warrants to acquire up to an aggregate of 1,935,485 shares of Common Stock (the “Warrants”) (collectively, the “Private Placement”).","confidence":0.98,"filing_url":"https://secwatch.observer/filing/0001104659-22-120092","anchor_url":"https://secwatch.observer/filing/0001104659-22-120092#claim-c9b8730a9d72f9bd9aaef9d21a16b4a1f0ac1924","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465922120092/0001104659-22-120092-index.htm"},{"fact_type":"executive_change","fact_key":"461df5f441","cik":1571934,"ticker":"TAOX","company_name":"TAO Synergies Inc.","filed_at":"2021-10-01T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2021-09-30","interim":false,"role":"Member of the Board of Directors","role_category":"director","successor_name":null,"successor_named":false},"claim":"George Perry resigned as Member of the Board of Directors at TAO Synergies Inc..","evidence_excerpt":"On September 30, 2021, George Perry resigned from his position as a member of the board of directors (the “Board”) of Synaptogenix, Inc. (the “Company”) and as a member of all committees of the Board on which he serves.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-21-122088","anchor_url":"https://secwatch.observer/filing/0001104659-21-122088#claim-461df5f441","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465921122088/0001104659-21-122088-index.htm"}]}